PERRIGO ISRAEL FDA Approval ANDA 077149

ANDA 077149

PERRIGO ISRAEL

FDA Drug Application

Application #077149

Documents

Letter2006-04-05

Application Sponsors

ANDA 077149PERRIGO ISRAEL

Marketing Status

Prescription001

Application Products

001SUPPOSITORY;VAGINAL80MG0TERCONAZOLETERCONAZOLE

FDA Submissions

ORIG1AP2006-03-17
LABELING; LabelingSUPPL4AP2016-02-20STANDARD

Submissions Property Types

SUPPL4Null15

TE Codes

001PrescriptionAB

CDER Filings

PERRIGO ISRAEL
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 77149
            [companyName] => PERRIGO ISRAEL
            [docInserts] => ["",""]
            [products] => [{"drugName":"TERCONAZOLE","activeIngredients":"TERCONAZOLE","strength":"80MG","dosageForm":"SUPPOSITORY;VAGINAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"Yes"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"TERCONAZOLE","submission":"TERCONAZOLE","actionType":"80MG","submissionClassification":"SUPPOSITORY;VAGINAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.